Click on a filter below to refine your search. Remove a filter to broaden your search.
A new online tool offers a prediction of how people with early-stage dementia are expected to develop worsening conditions such as Alzheimer’s.
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Wearable technology that measures spatial navigation and gait could improve detection of diseases that cause dementia, according to a new study.
In some cases, cognitive impairment is reversible, but up to one-third of individuals with stroke develop dementia within five years.
Two senior living communities have launched initiatives to elevate care for residents living with dementia and other cognitive issues.
Many senior living residents have Alzheimer’s, and artificial intelligence is an increasingly important tool in predicting the disease.
The cost of a 30-day readmission and total 30-day episode costs were higher for people living with Alzheimer’s disease and related dementias.
A new partnership between a speech therapy platform and a telehealth provider will expand offerings of speech therapy programs for seniors.
Risk for death, unplanned hospital admission significantly lower for those taking AChEIs only or taking AChEIs and memantine
The findings show a 40% higher risk among housing-insecure veterans.